MDXG Q3 2018 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$87M+2.8% YoY

Gross Profit

$80M91.5% margin

Operating Income

$373,0000.4% margin

Net Income

-$178,000-0.2% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-8.9%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$914,000

Stock-Based Comp.

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$85M	+2.8%
Gross Profit	$80M	$75M	+6.2%
Operating Income	$373,000	$9M	-95.8%
Net Income	-$178,000	$17M	-101.0%